158 related articles for article (PubMed ID: 28367093)
1. BEX2 promotes tumor proliferation in colorectal cancer.
Hu Y; Xiao Q; Chen H; He J; Tan Y; Liu Y; Wang Z; Yang Q; Shen X; Huang Y; Yuan Y; Ding K
Int J Biol Sci; 2017; 13(3):286-294. PubMed ID: 28367093
[TBL] [Abstract][Full Text] [Related]
2. Bex2 regulates cell proliferation and apoptosis in malignant glioma cells via the c-Jun NH2-terminal kinase pathway.
Zhou X; Meng Q; Xu X; Zhi T; Shi Q; Wang Y; Yu R
Biochem Biophys Res Commun; 2012 Oct; 427(3):574-80. PubMed ID: 23022184
[TBL] [Abstract][Full Text] [Related]
3. Silencing of brain-expressed X-linked 2 (BEX2) promotes colorectal cancer metastasis through the Hedgehog signaling pathway.
Tan Y; Hu Y; Xiao Q; Tang Y; Chen H; He J; Chen L; Jiang K; Wang Z; Yuan Y; Ding K
Int J Biol Sci; 2020; 16(2):228-238. PubMed ID: 31929751
[TBL] [Abstract][Full Text] [Related]
4. BEX2 has a functional interplay with c-Jun/JNK and p65/RelA in breast cancer.
Naderi A; Liu J; Hughes-Davies L
Mol Cancer; 2010 May; 9():111. PubMed ID: 20482821
[TBL] [Abstract][Full Text] [Related]
5. ROS/JNK/c-Jun axis is involved in oridonin-induced caspase-dependent apoptosis in human colorectal cancer cells.
Zhang D; Zhou Q; Huang D; He L; Zhang H; Hu B; Peng H; Ren D
Biochem Biophys Res Commun; 2019 Jun; 513(3):594-601. PubMed ID: 30981511
[TBL] [Abstract][Full Text] [Related]
6. Conflicting evidence for the role of JNK as a target in breast cancer cell proliferation: Comparisons between pharmacological inhibition and selective shRNA knockdown approaches.
Wood RA; Barbour MJ; Gould GW; Cunningham MR; Plevin RJ
Pharmacol Res Perspect; 2018 Feb; 6(1):. PubMed ID: 29417765
[TBL] [Abstract][Full Text] [Related]
7. PAK1-dependent MAPK pathway activation is required for colorectal cancer cell proliferation.
Qing H; Gong W; Che Y; Wang X; Peng L; Liang Y; Wang W; Deng Q; Zhang H; Jiang B
Tumour Biol; 2012 Aug; 33(4):985-94. PubMed ID: 22252525
[TBL] [Abstract][Full Text] [Related]
8. Molecular functions of brain expressed X-linked 2 (BEX2) in malignancies.
Naderi A
Exp Cell Res; 2019 Mar; 376(2):221-226. PubMed ID: 30779920
[TBL] [Abstract][Full Text] [Related]
9. TLE4 promotes colorectal cancer progression through activation of JNK/c-Jun signaling pathway.
Wang SY; Gao K; Deng DL; Cai JJ; Xiao ZY; He LQ; Jiao HL; Ye YP; Yang RW; Li TT; Liang L; Liao WT; Ding YQ
Oncotarget; 2016 Jan; 7(3):2878-88. PubMed ID: 26701208
[TBL] [Abstract][Full Text] [Related]
10. A feedback loop between BEX2 and ErbB2 mediated by c-Jun signaling in breast cancer.
Naderi A; Liu J; Francis GD
Int J Cancer; 2012 Jan; 130(1):71-82. PubMed ID: 21384344
[TBL] [Abstract][Full Text] [Related]
11. The transcription cofactor c-JUN mediates phenotype switching and BRAF inhibitor resistance in melanoma.
Ramsdale R; Jorissen RN; Li FZ; Al-Obaidi S; Ward T; Sheppard KE; Bukczynska PE; Young RJ; Boyle SE; Shackleton M; Bollag G; Long GV; Tulchinsky E; Rizos H; Pearson RB; McArthur GA; Dhillon AS; Ferrao PT
Sci Signal; 2015 Aug; 8(390):ra82. PubMed ID: 26286024
[TBL] [Abstract][Full Text] [Related]
12. miR-133a represses tumour growth and metastasis in colorectal cancer by targeting LIM and SH3 protein 1 and inhibiting the MAPK pathway.
Wang H; An H; Wang B; Liao Q; Li W; Jin X; Cui S; Zhang Y; Ding Y; Zhao L
Eur J Cancer; 2013 Dec; 49(18):3924-35. PubMed ID: 23968734
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of microRNA-135b and microRNA-182 promotes chemoresistance of colorectal cancer by targeting ST6GALNAC2 via PI3K/AKT pathway.
Liu B; Liu Y; Zhao L; Pan Y; Shan Y; Li Y; Jia L
Mol Carcinog; 2017 Dec; 56(12):2669-2680. PubMed ID: 28767179
[TBL] [Abstract][Full Text] [Related]
14. Cordycepin induces apoptosis by caveolin-1-mediated JNK regulation of Foxo3a in human lung adenocarcinoma.
Joo JC; Hwang JH; Jo E; Kim YR; Kim DJ; Lee KB; Park SJ; Jang IS
Oncotarget; 2017 Feb; 8(7):12211-12224. PubMed ID: 28099944
[TBL] [Abstract][Full Text] [Related]
15. Growth suppression of human mast cells expressing constitutively active c-kit receptors by JNK inhibitor SP600125.
Wang B; Tsukada J; Higashi T; Mizobe T; Matsuura A; Mouri F; Sawamukai N; Ra C; Tanaka Y
Genes Cells; 2006 Sep; 11(9):983-92. PubMed ID: 16923120
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of RhoB via c-Jun N-terminal kinase signaling induces apoptosis of the human gastric carcinoma NUGC-3 cells treated with NSC12618.
Kim BK; Kim HM; Chung KS; Kim DM; Park SK; Song A; Won KJ; Lee K; Oh YK; Lee K; Song KB; Simon JA; Han G; Won M
Carcinogenesis; 2011 Mar; 32(3):254-61. PubMed ID: 21084431
[TBL] [Abstract][Full Text] [Related]
17. JNK signaling mediates EPHA2-dependent tumor cell proliferation, motility, and cancer stem cell-like properties in non-small cell lung cancer.
Song W; Ma Y; Wang J; Brantley-Sieders D; Chen J
Cancer Res; 2014 May; 74(9):2444-54. PubMed ID: 24607842
[TBL] [Abstract][Full Text] [Related]
18. Nintedanib modulates surfactant protein-D expression in A549 human lung epithelial cells via the c-Jun N-terminal kinase-activator protein-1 pathway.
Kamio K; Usuki J; Azuma A; Matsuda K; Ishii T; Inomata M; Hayashi H; Kokuho N; Fujita K; Saito Y; Miya T; Gemma A
Pulm Pharmacol Ther; 2015 Jun; 32():29-36. PubMed ID: 25843005
[TBL] [Abstract][Full Text] [Related]
19. Quercetin preferentially induces apoptosis in KRAS-mutant colorectal cancer cells via JNK signaling pathways.
Yang Y; Wang T; Chen D; Ma Q; Zheng Y; Liao S; Wang Y; Zhang J
Cell Biol Int; 2019 Feb; 43(2):117-124. PubMed ID: 30203888
[TBL] [Abstract][Full Text] [Related]
20. Targeting the JNK signaling pathway potentiates the antiproliferative efficacy of rapamycin in LS174T colon cancer cells.
Benoit M; Dormond-Meuwly A; Demartines N; Dormond O
J Surg Res; 2011 May; 167(2):e193-8. PubMed ID: 21324487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
